Free Trial
OTCMKTS:CUBT

Curative Biotechnology (CUBT) Stock Price, News & Analysis

Curative Biotechnology logo
$0.01 0.00 (-8.72%)
As of 05/27/2025 03:59 PM Eastern

About Curative Biotechnology Stock (OTCMKTS:CUBT)

Key Stats

Today's Range
$0.0120
$0.0148
50-Day Range
$0.0095
$0.0155
52-Week Range
$0.00
$0.03
Volume
25,165 shs
Average Volume
167,229 shs
Market Capitalization
$13.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Curative Biotechnology, Inc., a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. The company has an agreement with Mid-Atlantic BioTherapeutics, Inc. to develop the COVID-19 vaccine. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida.

Receive CUBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curative Biotechnology and its competitors with MarketBeat's FREE daily newsletter.

CUBT Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
SFRX Seafarer Exploration Corp.
See More Headlines

CUBT Stock Analysis - Frequently Asked Questions

Curative Biotechnology's stock was trading at $0.0128 on January 1st, 2025. Since then, CUBT shares have increased by 6.2% and is now trading at $0.0136.
View the best growth stocks for 2025 here
.

Shares of CUBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Curative Biotechnology investors own include Ayala Pharmaceuticals (ADXS), Curative Biotechnology (CTYX), Invesco S&P Global Water Index ETF (CGW), Surge Battery Metals (NILIF), HEXO (HEXO), Pressure BioSciences (PBIO) and TransAtlantic Capital (TACI).

Company Calendar

Today
5/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
OTCMKTS:CUBT
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$13.18 million
Optionable
Not Optionable
Beta
0.28
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:CUBT) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners